New hepatitis C model opens the way for new treatments for hepatitis C treatment

Release date: 2013-08-09

Researchers from the Icahn School of Medicine in New York say that through a new hepatitis C model, humans may soon open up new drugs. So far, human understanding of hepatitis C has been limited to its replication process in humans and chimpanzees. Their research reveals the phenomenon of differentiated stem cells in hepatitis C virus infection, which also provides new ideas for revealing the pathogenesis of hepatitis C. Hepatitis C is a major disease that afflicts countries around the world. In the United States alone, 3 million people are infected with hepatitis C.


Source: New hepatitis C model opens the way for new treatments for hepatitis C treatment

IVD PCR Nucleic Acid Test

This kit is a real-time RT-PCR test intended for the qualitative detection of DNA from the
Monkeypox virus in human oropharyngeal swabs, whole blood, vesicular fluid and pustular fluid
specimens.
Positive results are indicative of the presence of Monkeypox virus DNA; clinical correlation with
patient history and other diagnostic information is necessary to determine patient infection status.
Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected
may not be the definite cause of disease.
Negative results do not preclude Monkeypox virus infection and should not be used as the sole
basis for patient management decisions. Negative results must be combined with clinical observations,
patient history, and epidemiological information to make decision.
This kit is intended to be performed by trained users in both laboratory and near patient testing
settings.
This kit is for in vitro diagnostic use only

EPIDEMIC INFECTIOUS DISEASE Monkeypox Virus Nucleic Acid Test Kit (PCR- fluorescenceprobe method)

Guangdong Hecin Scientific, Inc. , https://www.hecinscientific.com